AIDS InfoNet Logo
This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

The Henry J. Kaiser Family Foundation
Site of the Week
November 2003

The Health Leader Award 2006
The Health Leader Award 2006

The HOPE Reward Medical Award Featured Site Award

IBS Tales Hope Award Editor's Choice Award

Listed in Listed in Treasures of the Internet

AIDS InfoNet Logo.  The AIDS InfoNet - Reliable, Up-to-Date AIDS Treatment Information
International Association of Providers of AIDS Care
Reviewed June 13, 2016

Fact Sheet 442

Ritonavir (Norvir)



 Ritonavir is a drug used as part of antiretroviral therapy (ART). It is also called Norvir. It is manufactured by Abbott Laboratories. Ritonavir is a protease inhibitor. These drugs prevent the protease enzyme from working. HIV protease acts like a chemical scissors. It cuts the raw material for HIV into specific pieces needed to build a new virus. Protease inhibitors “gum up” these scissors.



Ritonavir was approved in 1996 as an antiretroviral drug (ARV) for people with HIV infection. It was studied in adults and children 1 month old and older.

While antiretroviral therapy (ART) is recommended for all people living with HIV, independent of your symptoms or CD4 count, you and your health care provider should consider your CD4 cell count, your viral load, any symptoms you are having, and your attitude about taking ART. Fact Sheet 404 has more information about guidelines for the use of ART.

If you take ritonavir with other ARVs, you can reduce your viral load to extremely low levels, and increase your CD4 cell counts. This should mean staying healthier longer.

Ritonavir makes the liver work more slowly. This can increase the blood levels of some drugs, including other protease inhibitors. This can cause some dangerous interactions with other drugs.

Ritonavir is rarely used as a protease inhibitor any more. It is difficult for patients to tolerate. However, ritonavir is frequently used to increase (boost) blood levels of other HIV medications, including protease inhibitors and the integrase inhibitor elvitegravir (fact sheet 466). The dose used for boosting is much smaller than the full anti-HIV dose and causes fewer side effects.



Many new copies of HIV are mutations. They are slightly different from the original virus. Some mutations can keep multiplying even when you are taking an ARV. When this happens, the drug will stop working. This is called “developing resistance” to the drug. See Fact Sheet 126 for more information on resistance.

Resistance can develop quickly. It is very important to take ARVs according to instructions, on schedule, and not to skip or reduce doses.



Ritonavir is taken by mouth as a liquid, capsule or tablet. The full dose (when ritonavir is the only protease inhibitor) is 600 milligrams (mg) twice a day. However, ritonavir is almost never used this way any more. Ritonavir was approved for use by children over 1 month old at a dose of 350 to 400 mg per square meter of body area.

Ritonavir is mostly used to increase the blood levels of other protease inhibitors. Usually 100 or 200 mg are taken with each dose. Be sure you know how much ritonavir your health care provider has prescribed for you, and when and how to take each dose.

A small amount of ritonavir is included in capsules of Kaletra as a booster. Kaletra is also manufactured by Abbott.

Your pharmacist must keep the ritonavir soft-gel capsules refrigerated. You should keep ritonavir in your refrigerator, but it can also stay out at room temperature (below 77 degrees F, or 25 degrees C) for up to 30 days. 

A new 100 mg tablet was approved in 2010. It does not need to be refrigerated. The tablet must be taken with a meal.



The most serious side effects are nausea, vomiting, gas, and diarrhea. Some people also experience tingling or numbness around the mouth, or find that foods taste strange. . In rare cases, ritonavir can cause a serious skin disease called Stevens-Johnson syndrome. This can be fatal. Tell your health care provider if you have any skin problems while taking ritonavir.

Side effects made about one-third of people stop taking ritonavir in some clinical trials. However, there are far less side effects with the lower “booster” doses of ritonavir.

For many people, the side effects of ritonavir lasted only 2 to 4 weeks. If they lasted beyond 4 weeks, in most cases they were permanent.



Ritonavir can interact with other drugs or supplements that you are taking. These interactions can change the amount of each drug in your bloodstream and cause an under- or overdose. New interactions are being identified all the time.

There can be dangerous interactions with drugs for pulmonary arterial hypertension or erectile dysfunction such as sildenafil (Viagra) or other drugs with names ending in “-afil”, drugs to treat asthma, and for heart rhythm (antiarrhythmics.) Taking ritonavir together with saquinavir can cause an irregular heartbeat. Other drugs to watch out for include other ARVs, drugs to treat tuberculosis (see fact sheet 518), and for migraine headaches. Interactions are also possible with several antihistamines (allergy medications), sedatives, drugs to lower cholesterol and anti-fungal drugs. Make sure that your health care provider knows about ALL drugs and supplements you are taking.

Ritonavir lowers blood levels of methadone. Watch for signs of excessive sedation if you take ritonavir with buprenorphine.

Some birth control pills may not work if you are taking ritonavir. Talk to your health care provider about how to prevent an unwanted pregnancy.

The herb St. John's Wort (See Fact Sheet 729) lowers the blood levels of some protease inhibitors. Do not take it with ritonavir.




Back to Fact Sheet Categories

International Association of Providers of AIDS Care


The AIDS InfoNet is a project of the International Association of Providers of AIDS Care.


United States National Library of Medicine

Partially funded by the National Library of Medicine

Search Our Site
Newest Fact Sheets
Print This Fact Sheet
You can print this fact sheet on a single page in Microsoft Word (.doc) format or Adobe Acrobat (.pdf) format. Click on the links below to open the document in your browser and then print it.
 Adobe Acrobat PDF
 Microsoft Word

You can print directly from your browser using the link below. The printout will probably go onto a second page.
 Print Version (Web)

Monthly E-mail Updates

The InfoNet updates its Fact Sheets frequently. A listing of each month's changes is posted to several e-mail lists.

If you would like to receive this monthly update by personal e-mail, please click on the SUBMIT button.